Dynasil Corporation of America (DYSL)
Stock Price Chart
Key Info
| Market Cap | 15.75M |
| Revenue (ttm) | 43.70M |
| Net Income (ttm) | -370,000 |
| Shares Out | 15.00M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Aug 3, 2020 |
| Last Price | $1.05 |
| Previous Close | $1.08 |
| Change ($) | -0.03 |
| Change (%) | -2.78% |
| Day's Open | 1.11 |
| Day's Range | 0.89 - 1.05 |
| Day's Volume | 394 |
| 52-Week Range | 0.73 - 1.85 |
More Stats
| Market Cap | 15.75M |
| Enterprise Value | 21.52M |
| Earnings Date (est) | n/a |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 15.00M |
| Float | 5.01M |
| EPS (basic) | -0.02 |
| EPS (diluted) | -0.02 |
| FCF / Share | -0.08 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 12,570 |
| Short Ratio | 0.17 |
| Short % of Float | 0.13% |
| Beta | 0.26 |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | 0.36 |
| PB Ratio | 0.86 |
| Revenue | 43.70M |
| Operating Income | 12,000 |
| Net Income | -370,000 |
| Free Cash Flow | -1.40M |
| Net Cash | -5.76M |
| Net Cash / Share | -0.38 |
| Gross Margin | 36.78% |
| Operating Margin | 0.03% |
| Profit Margin | -0.80% |
| FCF Margin | -3.21% |
| ROA | 0.02% |
| ROE | -1.91% |
| ROIC | 0.20% |
Analyst Summary
Analyst Consensus: n/a
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 43.70 | 40.68 | 37.28 | 43.44 | 40.54 | 42.31 | 42.75 | 47.89 | 46.95 | 42.97 |
| Revenue Growth | 7.42% | 9.11% | -14.18% | 7.17% | -4.19% | -1.04% | -10.72% | 1.99% | 9.27% | - |
| Gross Profit | 16.07 | 15.24 | 13.90 | 15.60 | 14.99 | 16.73 | 18.09 | 19.51 | 19.75 | 17.76 |
| Operating Income | 0.01 | 0.16 | -0.58 | 0.68 | 0.13 | 2.70 | -8.17 | -3.71 | 2.29 | 4.79 |
| Net Income | -0.37 | 1.76 | 2.19 | 0.69 | -0.23 | 2.07 | -8.73 | -4.30 | 1.35 | 3.23 |
| Shares Outstanding | 17.05 | 17.16 | 16.91 | 16.66 | 16.40 | 15.42 | 14.81 | 14.81 | 14.93 | 12.40 |
| Earnings Per Share | -0.02 | 0.10 | 0.13 | 0.04 | -0.01 | 0.13 | -0.59 | -0.29 | 0.08 | 0.22 |
| EPS Growth | - | -23.08% | 225% | - | - | - | - | - | -63.64% | - |
| Operating Cash Flow | -0.51 | 2.13 | 1.49 | 2.11 | 0.84 | 1.90 | 1.70 | 0.69 | 3.89 | 3.11 |
| Capital Expenditures | -0.89 | -2.32 | -0.98 | -1.61 | -1.31 | -1.45 | -0.55 | -1.02 | -1.54 | -0.36 |
| Free Cash Flow | -1.40 | -0.19 | 0.51 | 0.50 | -0.47 | 0.45 | 1.16 | -0.33 | 2.35 | 2.75 |
| Cash & Equivalents | 0.27 | 2.33 | 2.42 | 2.61 | 1.30 | 3.84 | 2.44 | 3.41 | 4.48 | 4.11 |
| Total Debt | 6.03 | 3.41 | 3.22 | 6.58 | 5.10 | 7.27 | 10.18 | 11.98 | 10.85 | 12.70 |
| Net Cash / Debt | -5.76 | -1.09 | -0.81 | -3.97 | -3.80 | -3.43 | -7.74 | -8.57 | -6.37 | -8.59 |
| Assets | 30.83 | 31.53 | 29.10 | 26.37 | 24.50 | 26.38 | 26.68 | 37.47 | 40.87 | 40.11 |
| Liabilities | 12.04 | 9.20 | 8.67 | 11.70 | 10.08 | 12.06 | 16.03 | 18.62 | 18.62 | 20.12 |
| Book Value | 17.52 | 21.03 | 18.97 | 14.97 | 14.62 | 14.38 | 10.65 | 18.84 | 22.24 | 19.99 |
Company Profile
Company Details
| Full Name | Dynasil Corporation of America |
| Country | United States |
| Employees | 207 |
| CEO | Peter Sulick |
Stock Information
| Ticker Symbol | DYSL |
| Stock Exchange | US OTC |
| Sector | Technology |
| Industry | Scientific & Technical Instruments |
| Unique Identifier | OTCMKTS: DYSL |
Description
Dynasil Corporation of America develops, markets, manufactures, and sells detection, sensing, and analysis technology and optical components in the United States, Asia, Europe, and internationally. It operates through Optics, Innovation and Development, and Biomedical segments. The Optics segment supplies synthetic crystals, optical materials, components, and coatings that are used in devices, such as baggage scanners, medical imaging systems, optical instruments, lasers, analytical instruments, automotive components, semiconductor/electronic devices, spacecraft/aircraft components, and advertising displays in the medical, industrial, and homeland security/defense sectors. The Innovation and Development segment develops advanced technology in materials, sensors, and prototype instruments that detect or measure radiation, light, magnetism, or sound for use in security, medical, and industrial applications. The Biomedical segment engages in the development of tissue sealant products. The company distributes its products through direct sales and marketing staff, as well as through manufacturer's representatives and distributors. Dynasil Corporation of America was founded in 1960 and is headquartered in Newton, Massachusetts.